ANDA 73519, held by Ani Pharms. Tolmetin Sodium.
As of Nov 16, 2026, ANDA 73519 (Tolmetin Sodium), held by Ani Pharms, was first approved by FDA on May 29, 1992, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 29, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tolmetin SodiumEQ 400MG BASE · capsule;oral | Tolmetin Sodium | Discontinued |
| Apr 28, 2021 | Supplement 10Labeling · Standard review | Approved | None posted |
| May 9, 2016 | Supplement 9Labeling · Standard review | Approved | None posted |
| Dec 2, 1999 | Supplement 8Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 7Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 3Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 2Manufacturing | Approved | None posted |
| Aug 16, 1996 | Supplement 1Manufacturing | Approved | None posted |
| May 29, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters